Aier Eye Hospital Group Co., Ltd. (SHE:300015)

Market Cap	78.87B -36.7%
Revenue (ttm)	22.72B +4.2%
Net Income	3.37B -9.0%
EPS	0.36 -9.3%
Shares Out	9.27B
PE Ratio	23.41
Forward PE	22.98
Dividend	0.20 (2.37%)
Ex-Dividend Date	Jul 17, 2026

Volume	41,113,276
Open	8.32
Previous Close	8.51
Day's Range	8.32 - 8.58
52-Week Range	7.82 - 13.95
Beta	0.39
Analysts	Buy
Price Target	13.59 (+59.32%)
Earnings Date	Aug 28, 2026

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2002
• Employees: 42,817
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300015

Financial Performance

In 2025, Aier Eye Hospital Group's revenue was 22.35 billion, an increase of 6.53% compared to the previous year's 20.98 billion. Earnings were 3.24 billion, a decrease of -8.88%.

Analyst Summary

According to 17 analysts, the average rating for 300015 stock is "Buy." The 12-month stock price target is ¥13.59, which is an increase of 59.32% from the latest price.

Price Target

¥13.59

(59.32% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error